Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: i am long but...

Dec 27, 2007 11:27AM
25
Dec 27, 2007 11:37AM
2
Dec 27, 2007 11:43AM
1
Dec 27, 2007 11:52AM
4
Dec 27, 2007 11:57AM

Dec 27, 2007 12:06PM
7
Dec 27, 2007 12:32PM

Agreed - 'Round and round the posts go: from knowing and understanding this is a speculative stock with its future hinging on USPTO acceptance of the patents, to the grumblings that JT should be doing this, or that, etc, etc...

Fact: 

1)  PTSC is a pure spec play until 336 validation by the USPTO. The market has been correct in treating it as such.

2) JT (and the rest of PTSC) is in a holding pattern until 336 Validation. From a self-preservation standpoint, this Company is smart for sitting on the $20M until they know ehich end is up.

If it plays out, there may be a future. If not, we're back to .04....and probably a "gone" $20M. lol.....Either way, JT will probably be doing something else.

3) Announced license up until USPTO validation (assumed) at levels to sustain TPL and PTSC in a holding pattern (pay salaries). Infringers know this, hence the low figures.

4) J3 numbers will probably be along the same pattern, but I'll bet there's a clause allowing for a rate adjustment IF the patents come back clean. If not, TPL lawyers didn't do their job.

I suspect we will know where things really stand and what really matters in about 30-45 days, and I'm not talking about the 10K...

Not FUD, just facts.

Regards 

 

8
Dec 27, 2007 01:08PM
2
Dec 27, 2007 01:08PM
1
Dec 27, 2007 01:14PM
4
Dec 27, 2007 01:22PM
1
Dec 27, 2007 02:11PM
3
Dec 27, 2007 04:13PM
3
Dec 27, 2007 04:19PM
1
Dec 27, 2007 07:11PM
1
Dec 27, 2007 07:35PM
2
Dec 27, 2007 09:35PM
Share
New Message
Please login to post a reply